Plasma biglycan identified by DIA proteomics as a biomarker for differential diagnosis of perimesencephalic non-aneurysmal and aneurysmal subarachnoid hemorrhage.
OBJECTIVE The aim of this study is to elucidate the molecular heterogeneity of perimesencephalic non-aneurysmal subarachnoid hemorrhage (pmSAH), non-perimesencephalic non-aneurysmal subarachnoid hemorrhage (npmSAH) and aneurysmal subarachnoid hemorrhage (aSAH), reveal the unique pathological features of pmSAH, and scre...